Download PDF
Semin intervent Radiol 2024; 41(03): 302-308
DOI: 10.1055/s-0044-1788622
Review Article

Prostate Artery Embolization with 4D-CT

Andras Bibok
1   Department of Interventional Radiology, Semmelweis University, Budapest, Hungary
2   Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, Tampa, Florida
,
Bela Kis
2   Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, Tampa, Florida
,
Nainesh Parikh
2   Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, Tampa, Florida
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Prostate artery embolization (PAE) is a technically challenging angiographic therapy that has been shown to have excellent clinical outcomes for men with benign prostatic hyperplasia and lower urinary tract symptoms. Although clinical outcomes have been well documented, several questions remain regarding various technical details of the procedure. This article is a brief review of indications and technical parameters of PAE as well as commonly debated topics throughout the literature. Finally, the article serves to report tips and tricks from a high-volume center.

Keywords

benign prostatic hyperplasia - therapeutic embolization - interventional radiology


Publication History

Article published online:
19 August 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008; 20 (Suppl. 03) S11-S18
    CrossrefPubMedSearch in Google Scholar
  • 2 Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol 2005; 7 Suppl 9 (Suppl. 09) S3-S14
    PubMedSearch in Google Scholar
  • 3 Barry MJ, Fowler Jr FJ, Bin L, Pitts III JC, Harris CJ, Mulley Jr AG. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol 1997; 157 (01) 10-14 , discussion 14–15
    CrossrefPubMedSearch in Google Scholar
  • 4 Barry MJ, Fowler Jr FJ, O'leary MP. et al; Measurement Committee of the American Urological Association. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 2017; 197 (2S): S189-S197
    CrossrefPubMedSearch in Google Scholar
  • 5 Abrams P, Cardozo L, Fall M. et al; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21 (02) 167-178
    CrossrefPubMedSearch in Google Scholar
  • 6 McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006; 12 (5, Suppl): S122-S128
    PubMedSearch in Google Scholar
  • 7 Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 2016; 43 (03) 289-297
    CrossrefPubMedSearch in Google Scholar
  • 8 Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173 (04) 1256-1261
    CrossrefPubMedSearch in Google Scholar
  • 9 Cornelis FH, Bilhim T, Hacking N, Sapoval M, Tapping CR, Carnevale FC. CIRSE standards of practice on prostatic artery embolisation. Cardiovasc Intervent Radiol 2020; 43 (02) 176-185
    CrossrefPubMedSearch in Google Scholar
  • 10 Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 2011; 22 (01) 11-19 , quiz 20
    CrossrefPubMedSearch in Google Scholar
  • 11 Sandhu JS, Bixler BR, Dahm P. et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA Guideline Amendment 2023. J Urol 2024; 211 (01) 11-19
    CrossrefPubMedSearch in Google Scholar
  • 12 Abt D, Müllhaupt G, Hechelhammer L. et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial. Eur Urol 2021; 80 (01) 34-42
    CrossrefPubMedSearch in Google Scholar
  • 13 Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol 2016; 27 (11) 1686-1697.e8
    CrossrefPubMedSearch in Google Scholar
  • 14 Vogl TJ, Zinn A, Elhawash E, Alizadeh LS, Nour-Eldin NA, Naguib NNN. MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: single-center retrospective study in 56 patients. Diagn Interv Radiol 2021; 27 (06) 725-731
    CrossrefPubMedSearch in Google Scholar
  • 15 Bagla S, Rholl KS, Sterling KM. et al. Utility of cone-beam CT imaging in prostatic artery embolization. J Vasc Interv Radiol 2013; 24 (11) 1603-1607
    CrossrefPubMedSearch in Google Scholar
  • 16 Barral M, Lassalle L, Gardavaud F. et al. Virtual injection software reduces radiation exposure and procedural time of prostatic artery embolization performed with cone-beam CT. J Vasc Interv Radiol 2024; 35 (03) 409-415
    CrossrefPubMedSearch in Google Scholar
  • 17 Naidu SG, Narayanan H, Saini G. et al. Prostate artery embolization - review of indications, patient selection, techniques and results. J Clin Med 2021; 10 (21) 5139
    CrossrefPubMedSearch in Google Scholar
  • 18 Loffroy R, Guillen K, Salet E. et al. prostate artery embolization using N-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles?. J Clin Med 2021; 10 (14) 3161
    CrossrefPubMedSearch in Google Scholar
  • 19 Salet E, Crombé A, Grenier N. et al. Prostatic artery embolization for benign prostatic obstruction: single-centre retrospective study comparing microspheres versus N-butyl cyanoacrylate. Cardiovasc Intervent Radiol 2022; 45 (06) 814-823
    CrossrefPubMedSearch in Google Scholar
  • 20 Hijazi BA, Shi HB, Liu S, Alqurashi TA, Sabri ZJ. N-butyl cyanoacrylate glue versus nonspherical polyvinyl alcohol particles for prostatic arterial embolization to treat benign prostatic hyperplasia: safety and efficacy. Urol J 2023; 20 (04) 261-268
    PubMedSearch in Google Scholar
  • 21 Bilhim T, Pisco J, Pereira JA. et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology 2016; 281 (01) 289-300
    CrossrefPubMedSearch in Google Scholar
  • 22 Torres D, Costa NV, Pisco J, Pinheiro LC, Oliveira AG, Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm embospheres. J Vasc Interv Radiol 2019; 30 (05) 638-644
    CrossrefPubMedSearch in Google Scholar
  • 23 Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol 2014; 37 (06) 1602-1605
    CrossrefPubMedSearch in Google Scholar
  • 24 Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and PErFecTED Prostate Artery Embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol 2016; 39 (01) 44-52
    CrossrefPubMedSearch in Google Scholar
  • 25 Mirakhur A, McWilliams J. Prostate artery embolization for benign prostatic hyperplasia. Imaging Med 2015;7(02):
    PubMed
  • 26 Sapoval M, Thiounn N, Descazeaud A. et al; PARTEM Study Group. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur 2023; 31: 100672
    CrossrefPubMedSearch in Google Scholar
  • 27 Peacock J, Sikaria D, Maun-Garcia L, Javedan K, Yamoah K, Parikh N. A proof-of-concept study on the use of prostate artery embolization before definitive radiation therapy in prostate cancer. Adv Radiat Oncol 2020; 6 (03) 100619
    CrossrefPubMedSearch in Google Scholar
  • 28 Parikh N, Keshishian E, Manley B. et al. Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer. J Vasc Interv Radiol 2021; 32 (07) 1053-1061
    CrossrefPubMedSearch in Google Scholar
  • 29 Parikh N, Keshishian E, Sharma A. et al. Prostatic artery embolization is safe and effective for medically recalcitrant radiation-induced prostatitis. Adv Radiat Oncol 2020; 5 (05) 905-909
    CrossrefPubMedSearch in Google Scholar
  • 30 Parikh N, Manley B, Pow-Sang J, Yamoah K. A review of the role of prostatic artery embolization in the management of post-radiation prostatitis. AME Med J 2022; 7 (00)
    CrossrefPubMedSearch in Google Scholar
  • 31 Parikh N, Acharya V, Bhatia S. Prostate artery embolization - adverse events and peri-procedural management. Tech Vasc Interv Radiol 2020; 23 (03) 100692
    CrossrefPubMedSearch in Google Scholar
  • 32 Isaacson AJ, Fischman AM, Burke CT. Technical feasibility of prostatic artery embolization from a transradial approach. AJR Am J Roentgenol 2016; 206 (02) 442-444
    CrossrefPubMedSearch in Google Scholar
  • 33 Carnevale FC, Soares GR, de Assis AM, Moreira AM, Harward SH, Cerri GG. Anatomical variants in prostate artery embolization: a pictorial essay. Cardiovasc Intervent Radiol 2017; 40 (09) 1321-1337
    CrossrefPubMedSearch in Google Scholar
  • 34 Bibok A, Kis B, Parikh N. Does the use of a hybrid 4D angio-CT system significantly impact procedure time for prostate artery embolization?. J Vasc Intervent Radiol 2021; 32 (5, Suppl, S18)
    CrossrefPubMedSearch in Google Scholar
  • 35 Jazayeri-Moghaddas O, Parikh N. Novel predictive model for amount of embolic used as a percent of prostate size during PAE. J Vasc Intervent Radiol 2022; 33 (6, Suppl, S51)
    CrossrefPubMedSearch in Google Scholar
  • 36 Galla N, Maron SZ, Voutsinas N. et al. Adjunctive coil embolization of the prostatic arteries after particle embolization for prostatic artery embolization. Cardiovasc Intervent Radiol 2021; 44 (12) 1994-1998
    CrossrefPubMedSearch in Google Scholar